These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 2388483

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Pharmacological modification of multi-drug resistance (MDR) in vitro detected by a novel fluorometric microculture cytotoxicity assay. Reversal of resistance and selective cytotoxic actions of cyclosporin A and verapamil on MDR leukemia T-cells.
    Larsson R, Nygren P.
    Int J Cancer; 1990 Jul 15; 46(1):67-72. PubMed ID: 2194983
    [Abstract] [Full Text] [Related]

  • 3. Laboratory determination of chemotherapeutic drug resistance in tumor cells from patients with leukemia, using a fluorometric microculture cytotoxicity assay (FMCA).
    Larsson R, Kristensen J, Sandberg C, Nygren P.
    Int J Cancer; 1992 Jan 21; 50(2):177-85. PubMed ID: 1730510
    [Abstract] [Full Text] [Related]

  • 4. The fluorometric microculture cytotoxicity assay.
    Lindhagen E, Nygren P, Larsson R.
    Nat Protoc; 2008 Jan 21; 3(8):1364-9. PubMed ID: 18714304
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Use of the microculture kinetic assay of apoptosis to determine chemosensitivities of leukemias.
    Kravtsov VD, Greer JP, Whitlock JA, Koury MJ.
    Blood; 1998 Aug 01; 92(3):968-80. PubMed ID: 9680366
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Cytotoxic drug sensitivity testing of tumor cells from patients with ovarian carcinoma using the fluorometric microculture cytotoxicity assay (FMCA).
    Csoka K, Larsson R, Tholander B, Gerdin E, de la Torre M, Nygren P.
    Gynecol Oncol; 1994 Aug 01; 54(2):163-70. PubMed ID: 7520407
    [Abstract] [Full Text] [Related]

  • 10. Estimation of cell survival by flow cytometric quantification of fluorescein diacetate/propidium iodide viable cell number.
    Ross DD, Joneckis CC, Ordóñez JV, Sisk AM, Wu RK, Hamburger AW Nora RE, Nora RE.
    Cancer Res; 1989 Jul 15; 49(14):3776-82. PubMed ID: 2736519
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Chemosensitivity testing of fresh human leukemia cells using both a dye exclusion assay and a tetrazolium dye (MTT) assay.
    Kirkpatrick DL, Duke M, Goh TS.
    Leuk Res; 1990 Jul 15; 14(5):459-66. PubMed ID: 2345469
    [Abstract] [Full Text] [Related]

  • 13. In vitro chemosensitivity testing of leukemic cells: development of a semiautomated colorimetric assay.
    Bernabei PA, Santini V, Silvestro L, Dal Pozzo O, Bezzini R, Viano I, Gattei V, Saccardi R, Rossi Ferrini P.
    Hematol Oncol; 1989 Jul 15; 7(3):243-53. PubMed ID: 2707746
    [Abstract] [Full Text] [Related]

  • 14. In vitro analysis of drug resistance in tumor cells from patients with acute myelocytic leukemia.
    Kristensen J, Jonsson B, Sundström C, Nygren P, Larsson R.
    Med Oncol Tumor Pharmacother; 1992 Jul 15; 9(2):65-74. PubMed ID: 1341718
    [Abstract] [Full Text] [Related]

  • 15. A non-P-glycoprotein-mediated mechanism of vincristine transport which is affected by resistance modifiers and present in chemosensitive cells.
    Gruber A, Larsson R, Nygren P, Björkholm M, Peterson C.
    Leukemia; 1994 Jun 15; 8(6):985-9. PubMed ID: 7911547
    [Abstract] [Full Text] [Related]

  • 16. In vitro drug sensitivity testing of tumor cells from patients with non-Hodgkin's lymphoma using the fluorometric microculture cytotoxicity assay.
    Nygren P, Hagberg H, Glimelius B, Sundström C, Kristensen J, Christiansen I, Larsson R.
    Ann Oncol; 1994 Jun 15; 5 Suppl 1():127-31. PubMed ID: 8172809
    [Abstract] [Full Text] [Related]

  • 17. Cellular drug resistance profiles that might explain the prognostic value of immunophenotype and age in childhood acute lymphoblastic leukemia.
    Pieters R, Kaspers GJ, van Wering ER, Huismans DR, Loonen AH, Hählen K, Veerman AJ.
    Leukemia; 1993 Mar 15; 7(3):392-7. PubMed ID: 8445945
    [Abstract] [Full Text] [Related]

  • 18. Detection of tumor-specific cytotoxic drug activity in vitro using the fluorometric microculture cytotoxicity assay and primary cultures of tumor cells from patients.
    Nygren P, Fridborg H, Csoka K, Sundström C, de la Torre M, Kristensen J, Bergh J, Hagberg H, Glimelius B, Rastad J.
    Int J Cancer; 1994 Mar 01; 56(5):715-20. PubMed ID: 8314348
    [Abstract] [Full Text] [Related]

  • 19. Flow cytometric determination of the multidrug-resistant phenotype in acute leukemia.
    Maslak P, Hegewisch-Becker S, Godfrey L, Andreeff M.
    Cytometry; 1994 Sep 01; 17(1):84-93. PubMed ID: 8001461
    [Abstract] [Full Text] [Related]

  • 20. Comparison of the rapid automated MTT-assay with a dye exclusion assay for chemosensitivity testing in childhood leukaemia.
    Pieters R, Huismans DR, Leyva A, Veerman AJ.
    Br J Cancer; 1989 Feb 01; 59(2):217-20. PubMed ID: 2930687
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.